Cidofovir (cas 113852-37-2)☆
-
Add time:08/25/2019 Source:sciencedirect.com
Cidofovir is primarily indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS, and in the treatment of acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections in immunocompromised patients and in transplant recipients. Cidofovir selectively inhibits both CMV and HSV DNA polymerase. However, the effectiveness of cidofovir is limited by its nephrotoxicity, and its effects on renal function. Cidofovir must be administered with probenecid to delay its clearance by the kidney.
We also recommend Trading Suppliers and Manufacturers of Cidofovir (cas 113852-37-2). Pls Click Website Link as below: cas 113852-37-2 suppliers
Prev:Case reportAdenovirus pneumonia treated with Cidofovir (cas 113852-37-2) in an immunocompetent high school senior
Next:Infectious DiseaseEfficacy of Cidofovir (cas 113852-37-2) in Treatment of BK Virus–Induced Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplant Recipients) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Degrees of Dysplasia Based on Viral Typing in Patients With Cidofovir (cas 113852-37-2) Use and Recurrent Respiratory Papillomatosis09/02/2019
- Clinical Research: Supportive CareCidofovir (cas 113852-37-2) in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation09/01/2019
- Original breveTratamiento de verrugas anogenitales con Cidofovir (cas 113852-37-2) tópicoTreatment of anogenital warts with topical Cidofovir (cas 113852-37-2)08/31/2019
- In vitro susceptibility to ST-246 and Cidofovir (cas 113852-37-2) corroborates the phylogenetic separation of Brazilian Vaccinia virus into two clades08/30/2019
- Antiviral effect of Cidofovir (cas 113852-37-2) on parvovirus B19 replication08/29/2019
- Intralesional Cidofovir (cas 113852-37-2) injection for recurrent respiratory papillomatosis in Japan08/28/2019
- Treatment of intraurethral condylomata acuminata with surgery and Cidofovir (cas 113852-37-2) instillations in two immunocompromised patients and review of the literature08/27/2019
- Infectious DiseaseEfficacy of Cidofovir (cas 113852-37-2) in Treatment of BK Virus–Induced Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplant Recipients08/26/2019
- Case reportAdenovirus pneumonia treated with Cidofovir (cas 113852-37-2) in an immunocompetent high school senior08/24/2019
